ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2,1,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
3,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
4,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
7,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
7,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
9,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
10,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
10,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
11,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
12,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
13,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
14,1,Medulloblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
15,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
16,1,Pituitary-dependent Cushing's syndrome,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
17,1,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
18,1,Pinealoma,Pineal neoplasms,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
19,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
20,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
20,2,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
21,1,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
22,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
23,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,Y
24,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
25,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
25,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
26,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
27,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
28,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
28,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
28,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
28,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
29,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
30,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
31,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
31,2,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
31,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
31,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
32,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
32,2,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,Y
33,1,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
34,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
35,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
36,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
37,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
37,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
38,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
39,1,Lymphangioma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
40,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
40,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
40,3,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
41,1,Epiphysiolysis,Epiphyseal disorders,Bone disorders (excl congenital and fractures),Musc,N
42,1,Smear cervix,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
43,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
44,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
45,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
45,2,Headache,Headaches NEC,Headaches,Nerv,N
45,3,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
45,4,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
46,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
46,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
46,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
47,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
47,2,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
48,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
49,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
50,1,Osteochondrosis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
51,1,Osteochondrosis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
52,1,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
52,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
53,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
54,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
55,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
56,1,Bone development abnormal,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
57,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
58,1,Headache,Headaches NEC,Headaches,Nerv,N
58,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
59,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,2,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
60,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
61,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
62,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
62,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
63,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
64,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
66,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
67,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
68,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
70,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
71,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
71,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
72,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
73,1,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
74,1,Headache,Headaches NEC,Headaches,Nerv,N
74,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
74,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
74,4,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
75,1,Pineal neoplasm,Pineal neoplasms,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
76,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
77,1,Rhabdomyosarcoma,Rhabdomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
78,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
78,2,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
79,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
80,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
81,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
81,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
82,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
83,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
84,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
85,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
85,2,Head banging,Stereotypies and automatisms,Changes in physical activity,Psych,N
85,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
85,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
86,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
86,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
87,1,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
87,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
87,3,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
88,1,Perthes disease,Epiphyseal disorders,Bone disorders (excl congenital and fractures),Musc,N
89,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
90,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
90,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
91,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
92,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
93,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
94,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
95,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
95,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
95,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
95,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
96,1,Headache,Headaches NEC,Headaches,Nerv,N
96,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
97,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
98,1,Headache,Headaches NEC,Headaches,Nerv,N
99,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
100,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
100,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,Y
102,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
103,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
103,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
104,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
105,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
106,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
106,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
106,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
107,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
108,1,Neurofibromatosis,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
109,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
110,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
111,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
112,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
113,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
114,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
115,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
116,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
117,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
118,1,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
118,2,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
118,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
119,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
119,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
120,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
121,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
121,2,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
122,1,Acne,Acnes,Skin appendage conditions,Skin,N
123,1,Acne,Acnes,Skin appendage conditions,Skin,N
124,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
124,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
125,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
125,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
126,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
127,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
128,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
129,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
129,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
130,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
131,1,Brain stem haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
132,1,Headache,Headaches NEC,Headaches,Nerv,N
133,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
134,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
134,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
134,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
135,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
136,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,Y
136,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
137,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
138,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
138,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
138,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
139,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
140,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
141,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
141,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
142,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
143,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
143,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
144,1,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
145,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
146,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
147,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
147,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
147,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
148,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
149,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
150,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
150,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
151,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
152,1,Creutzfeldt-Jakob disease,Prion-associated disorders,Viral infectious disorders,Infec,Y
153,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
153,2,Headache,Headaches NEC,Headaches,Nerv,N
153,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
154,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
155,1,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
156,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
157,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
158,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
158,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
159,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
160,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
160,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
160,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
160,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,1,Headache,Headaches NEC,Headaches,Nerv,N
162,1,Ganglioneuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
163,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
164,1,Pancreatitis relapsing,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
165,1,Headache,Headaches NEC,Headaches,Nerv,N
166,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
167,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
167,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
168,1,Headache,Headaches NEC,Headaches,Nerv,N
169,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
170,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
171,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
172,1,Angiokeratoma,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
173,1,Creutzfeldt-Jakob disease,Prion-associated disorders,Viral infectious disorders,Infec,N
174,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
175,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
176,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
177,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
178,1,Pineal neoplasm,Pineal neoplasms,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
179,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
179,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
180,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,Y
181,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
182,1,Epiphysiolysis,Epiphyseal disorders,Bone disorders (excl congenital and fractures),Musc,N
183,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
184,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
185,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
186,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
186,2,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
187,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
188,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
188,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
189,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
189,2,Osteochondrosis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
190,1,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
191,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
192,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
193,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
194,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
194,2,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
195,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
196,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
196,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
197,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
197,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
198,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
198,2,Headache,Headaches NEC,Headaches,Nerv,N
198,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
199,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
199,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
200,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
201,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
201,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
201,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
201,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
202,1,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
203,1,Headache,Headaches NEC,Headaches,Nerv,N
204,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
204,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
204,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
205,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
206,1,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
207,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
207,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
208,1,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
209,1,Bone giant cell tumour,Bone neoplasms unspecified malignancy,Skeletal neoplasms malignant and unspecified,Neopl,N
210,1,Hemihypertrophy,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
211,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
211,2,Headache,Headaches NEC,Headaches,Nerv,N
212,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
213,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
213,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
214,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
214,3,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
215,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
216,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
217,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
218,1,Headache,Headaches NEC,Headaches,Nerv,N
219,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
219,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
219,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
219,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
220,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
220,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
220,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
221,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
222,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
223,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
223,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
223,3,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
223,4,Laryngocele,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
223,5,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
224,1,Medulloblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
224,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
225,1,Moyamoya disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
226,1,Laryngocele,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
227,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
228,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
228,2,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
228,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
229,1,Astrocytoma malignant,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
229,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
230,1,Acne,Acnes,Skin appendage conditions,Skin,N
230,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
231,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
231,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
231,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,1,Headache,Headaches NEC,Headaches,Nerv,N
232,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
232,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
233,1,Headache,Headaches NEC,Headaches,Nerv,N
233,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
233,3,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
233,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
234,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
234,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
235,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
235,2,Headache,Headaches NEC,Headaches,Nerv,N
236,1,Epiphysiolysis,Epiphyseal disorders,Bone disorders (excl congenital and fractures),Musc,N
237,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
237,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
237,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
238,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
239,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
240,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
240,2,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
240,3,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
240,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
241,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
242,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
243,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
243,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
243,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
243,4,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
243,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
244,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
244,2,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
245,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
246,1,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
247,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
247,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
247,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
247,4,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
247,5,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
247,6,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
247,7,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
247,8,Hyperphagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
247,9,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
247,10,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
247,11,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
247,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
248,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
248,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
249,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
249,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
249,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
250,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
250,2,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
251,1,Headache,Headaches NEC,Headaches,Nerv,N
251,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
251,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
252,1,Headache,Headaches NEC,Headaches,Nerv,N
252,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
252,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
253,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
253,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
253,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
253,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
253,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
253,6,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
253,7,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
254,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
254,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
255,1,Nasopharyngeal cancer recurrent,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
256,1,Chorioretinopathy,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
256,2,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
257,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
257,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
257,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
258,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
259,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
260,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
260,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
260,3,Headache,Headaches NEC,Headaches,Nerv,N
260,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
260,5,Upper respiratory tract inflammation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
261,1,Testis cancer,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
262,1,Teratoma,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
263,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,2,Germ cell cancer,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
264,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
265,1,CNS germinoma,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
266,1,Germ cell cancer,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
267,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
267,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
267,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
267,4,Mutism,Communications disorders,Communication disorders and disturbances,Psych,N
268,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
268,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
268,3,Headache,Headaches NEC,Headaches,Nerv,N
269,1,Germ cell cancer,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
269,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
270,1,Astrocytoma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
270,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
271,1,Teratoma,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
272,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
273,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
274,1,Creutzfeldt-Jakob disease,Prion-associated disorders,Viral infectious disorders,Infec,N
275,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
276,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
276,2,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
277,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
277,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
278,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
278,2,Headache,Headaches NEC,Headaches,Nerv,N
278,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
279,1,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
280,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
281,1,Spinal cord neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
282,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
282,2,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
283,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
284,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
284,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
285,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
286,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
287,1,Ependymoma malignant,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
288,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
288,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
288,3,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
289,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
289,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
289,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
289,4,Headache,Headaches NEC,Headaches,Nerv,N
289,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
289,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
289,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
289,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
290,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
291,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
291,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
291,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
291,4,Headache,Headaches NEC,Headaches,Nerv,N
291,5,Torticollis,Muscle tone abnormalities,Muscle disorders,Musc,N
292,1,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
293,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
294,1,Antibody test abnormal,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
294,2,Coombs test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
294,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
294,4,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
295,1,Arterial rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
295,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
295,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
295,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
295,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
295,6,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
296,1,Arterial rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
296,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
296,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
296,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
296,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
296,6,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
297,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
297,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
297,3,Headache,Headaches NEC,Headaches,Nerv,N
297,4,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
298,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
299,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
299,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
299,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
299,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
299,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
300,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
300,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
300,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,1,Astrocytoma malignant,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
302,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
303,1,Hepatoblastoma,Hepatoblastomas,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
304,1,Alveolar rhabdomyosarcoma,Rhabdomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
305,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
305,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
305,3,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
306,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
306,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
306,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
306,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
306,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
307,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
308,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
309,1,Headache,Headaches NEC,Headaches,Nerv,N
309,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
310,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
310,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
310,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
311,1,Pneumonia mycoplasmal,Mycoplasma infections,Mycoplasmal infectious disorders,Infec,N
312,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
312,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
313,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
314,1,Insulin-like growth factor decreased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
315,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
315,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
316,1,Epiphysiolysis,Epiphyseal disorders,Bone disorders (excl congenital and fractures),Musc,N
317,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
317,2,Urinary tract obstruction,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
318,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
318,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
318,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
318,4,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
318,5,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
318,6,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
318,7,Headache,Headaches NEC,Headaches,Nerv,N
318,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
318,9,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
319,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
319,2,Ganglioglioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
320,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
320,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
320,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
320,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
320,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
320,6,Headache,Headaches NEC,Headaches,Nerv,N
320,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
320,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
320,9,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
320,10,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
320,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
320,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
321,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
321,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
321,3,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
322,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
322,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
323,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
323,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
323,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
323,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
324,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
324,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
324,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
324,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
325,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
325,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
325,3,Hernia repair,Hernia repairs,Gastrointestinal therapeutic procedures,Surg,N
325,4,Oesophagogastric fundoplasty,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
325,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
326,1,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
327,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
327,2,Device failure,Device issues NEC,Device issues,Prod,N
327,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
328,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
328,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
328,3,Headache,Headaches NEC,Headaches,Nerv,N
328,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
329,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
329,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
329,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
330,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
331,1,Pneumonia respiratory syncytial viral,Respiratory syncytial viral infections,Viral infectious disorders,Infec,Y
331,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,Y
333,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
333,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
333,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
333,4,Intracranial mass,Structural brain disorders NEC,Structural brain disorders,Nerv,N
333,5,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
334,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
334,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
334,3,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
334,4,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
334,5,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
335,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
335,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
335,3,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
335,4,Headache,Headaches NEC,Headaches,Nerv,N
335,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
335,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
335,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
336,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
337,1,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
338,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
338,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
338,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
339,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
339,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
339,3,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
340,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
340,2,Headache,Headaches NEC,Headaches,Nerv,N
340,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
340,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
340,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
340,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
340,7,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
340,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
340,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
341,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
342,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
342,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
342,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
342,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
342,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
343,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
343,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
343,3,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
344,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
344,2,Viral myocarditis,Viral infections NEC,Viral infectious disorders,Infec,Y
345,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
345,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
345,3,Headache,Headaches NEC,Headaches,Nerv,N
345,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
345,5,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
345,6,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
346,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
347,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
347,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
347,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
347,4,Progressive cerebellar degeneration,Cerebellar disorders congenital,Neurological disorders congenital,Cong,N
347,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
348,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
348,2,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
348,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
348,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
348,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
348,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
349,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
350,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
351,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
352,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
353,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
354,1,Medulloblastoma recurrent,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
355,1,Prognathism,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
356,1,Headache,Headaches NEC,Headaches,Nerv,N
356,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
356,3,Optic nerve disorder,Visual pathway disorders,Vision disorders,Eye,N
357,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
358,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
359,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
359,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
359,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
359,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
359,5,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
360,1,Hepatic cancer recurrent,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
360,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
361,1,Pituitary tumour recurrent,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
362,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
362,2,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
363,1,Moyamoya disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
364,1,Cranial nerve palsies multiple,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
364,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
364,3,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
364,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
365,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
366,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
367,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
367,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
367,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
367,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
367,5,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
368,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
369,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
369,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
370,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
371,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
371,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
372,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
372,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
372,3,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
373,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
373,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
374,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
375,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
375,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
375,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
375,4,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
376,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
376,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
376,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
376,4,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
377,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
377,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
377,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
378,1,Migraine,Migraine headaches,Headaches,Nerv,N
379,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
380,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
380,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
381,1,Device issue,Device issues NEC,Device issues,Prod,N
381,2,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
381,3,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
381,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
381,5,Thyroxine abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
382,1,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
382,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
383,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
383,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
383,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
384,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
384,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
385,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
386,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
386,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
387,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
387,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
387,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
388,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
389,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
389,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
389,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
390,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
390,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
390,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
390,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
390,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
391,1,Lymphangiectasia,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
392,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
392,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
392,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
392,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
393,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
393,2,Headache,Headaches NEC,Headaches,Nerv,N
394,1,Epiphysiolysis,Epiphyseal disorders,Bone disorders (excl congenital and fractures),Musc,N
395,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
395,2,Lymphangiectasia,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
395,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
396,1,Tumour flare,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
397,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
397,2,Headache,Headaches NEC,Headaches,Nerv,N
397,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
398,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
399,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
399,2,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
400,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
401,1,Acanthosis nigricans,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
401,2,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
401,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
401,4,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
401,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
401,6,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
401,7,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
401,8,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
401,9,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
402,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
402,2,Uterine polyp,Uterine neoplasms,"Uterine, pelvic and broad ligament disorders",Repro,N
403,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
403,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
403,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
404,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
405,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
406,1,Hepatoblastoma,Hepatoblastomas,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
407,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
408,1,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
408,2,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
409,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
410,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
410,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
411,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
412,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
413,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
413,2,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
413,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
413,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
413,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
414,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
414,2,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
415,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
416,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
417,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
417,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
418,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
419,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
420,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
420,2,Creutzfeldt-Jakob disease,Prion-associated disorders,Viral infectious disorders,Infec,N
421,1,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
421,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
422,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
423,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
424,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
424,2,Device failure,Device issues NEC,Device issues,Prod,N
424,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
425,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
425,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
425,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
426,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
426,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
426,3,Headache,Headaches NEC,Headaches,Nerv,N
426,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
426,5,Pseudomonas aeruginosa meningitis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
426,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
427,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
427,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
427,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
427,4,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
427,5,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
427,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
427,7,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
428,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
428,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
428,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
428,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
428,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
428,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
429,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
429,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
429,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
429,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
429,5,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
430,1,Fibrous dysplasia of bone,Non-site specific bone disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
431,1,Carbon monoxide poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
431,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
431,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
431,4,Headache,Headaches NEC,Headaches,Nerv,N
431,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
431,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
431,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
431,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
432,1,Budd-Chiari syndrome,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
433,1,Pancreatic steatosis,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
434,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
435,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
436,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
436,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
436,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
437,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
437,2,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
437,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
437,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
437,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
437,6,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
438,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
439,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
440,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
441,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
441,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
442,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
443,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
444,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
444,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
445,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
445,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
446,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
446,2,Cerebral mass effect,Structural brain disorders NEC,Structural brain disorders,Nerv,N
446,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
446,4,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
446,5,Headache,Headaches NEC,Headaches,Nerv,N
446,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
446,7,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
446,8,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
446,9,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
446,10,Vasogenic cerebral oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
446,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
447,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
448,1,Cancer pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
448,2,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
449,1,Headache,Headaches NEC,Headaches,Nerv,N
449,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
450,1,Headache,Headaches NEC,Headaches,Nerv,N
450,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
451,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
452,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
452,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
453,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
454,1,Osteosarcoma,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
455,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
456,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
457,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
458,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
458,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
458,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
458,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
458,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
458,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
459,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
459,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
459,3,Headache,Headaches NEC,Headaches,Nerv,N
459,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
459,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
459,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
460,1,Pharyngeal abscess,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
460,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
461,1,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
461,2,Headache,Headaches NEC,Headaches,Nerv,N
461,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
462,1,Prostate cancer recurrent,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
463,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
463,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
464,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
464,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
464,3,Intervertebral disc compression,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
465,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
466,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
466,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
466,3,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
467,1,Ependymoma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
467,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
468,1,Blood growth hormone abnormal,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
468,2,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
469,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
470,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
470,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
470,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
470,4,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
471,1,Headache,Headaches NEC,Headaches,Nerv,N
471,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
472,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
473,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
473,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
473,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
473,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
474,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
475,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
476,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
477,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
477,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
477,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
478,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
479,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
480,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
480,2,Pituitary tumour recurrent,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
481,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
481,2,Lymphatic disorder,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
481,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
482,1,Pulmonary valve incompetence,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
483,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
483,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
483,3,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
484,1,Carcinoid tumour of the gastrointestinal tract,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
485,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
485,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
485,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
485,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
485,5,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
485,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
485,7,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
486,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
486,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
486,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
487,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
487,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
487,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
488,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
489,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
489,2,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
489,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
490,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
490,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
491,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
491,2,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
491,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
492,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
492,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
492,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
493,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
494,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
495,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
496,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
497,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
498,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,Y
499,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
500,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
500,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
501,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
501,2,Headache,Headaches NEC,Headaches,Nerv,N
501,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
501,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
502,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
502,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
502,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
503,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
503,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
503,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
504,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
504,2,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
505,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
506,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
507,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
508,1,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
509,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
510,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
511,1,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
511,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
512,1,Creutzfeldt-Jakob disease,Prion-associated disorders,Viral infectious disorders,Infec,Y
513,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
513,2,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
513,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
514,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
515,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
516,1,Spinal cord neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
517,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
518,1,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
518,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
519,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
520,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
521,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
521,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
521,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
522,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
522,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
522,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
522,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
522,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
523,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
523,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
523,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
523,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
524,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
524,2,Germ cell cancer,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
524,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
524,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
525,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
525,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
525,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
525,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
526,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
526,2,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
527,1,Alveolar rhabdomyosarcoma,Rhabdomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
527,2,Bone marrow infiltration,Haematological disorders,Haematological disorders NEC,Blood,N
527,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
527,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
527,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
527,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
527,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
527,8,Pleural disorder,Pleural conditions NEC,Pleural disorders,Resp,N
527,9,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
527,10,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
528,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
529,1,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
530,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
531,1,Patella fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
532,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
532,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
533,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
533,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
533,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
533,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
533,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
534,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
534,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
534,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
534,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
534,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
535,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
536,1,Aneurysmal bone cyst,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
536,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
536,3,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
536,4,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
536,5,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
536,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
536,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
537,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
537,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
538,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
538,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
538,3,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
539,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
539,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
539,3,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
539,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
539,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
539,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
540,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
540,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
540,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
540,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
540,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
540,6,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
540,7,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
541,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
541,2,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
541,3,Headache,Headaches NEC,Headaches,Nerv,N
541,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
542,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
542,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
543,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
543,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
544,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
545,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
545,2,Device issue,Device issues NEC,Device issues,Prod,N
545,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
545,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
545,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
545,6,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
546,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
546,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
547,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
548,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
549,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
549,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
550,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
550,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
550,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
550,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
551,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
551,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
552,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
553,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
554,1,Disability,Disability issues,Lifestyle issues,SocCi,N
554,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
554,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
554,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
555,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
556,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
556,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
556,3,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
556,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
557,1,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
558,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
558,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
558,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
559,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
559,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
559,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
560,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
561,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
561,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
561,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
561,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
562,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
562,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
563,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
564,1,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
565,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
566,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
566,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
566,3,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
567,1,Vulval cancer,Vulval neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
568,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
568,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
569,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
570,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
570,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
571,1,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
572,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
572,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
573,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
574,1,Headache,Headaches NEC,Headaches,Nerv,N
575,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
575,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
576,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
576,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
577,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
577,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
578,1,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
578,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
579,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
579,2,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
579,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
579,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
579,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
580,1,Device issue,Device issues NEC,Device issues,Prod,N
580,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
580,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
581,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
582,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
582,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
583,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
583,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
584,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
584,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
585,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
585,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
586,1,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
587,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
588,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
589,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
590,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
590,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
591,1,Ependymoma malignant,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
592,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
592,2,Pituitary apoplexy,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
593,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
593,2,Pituitary apoplexy,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
594,1,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
595,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
595,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
595,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
595,4,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
595,5,Social problem,Social issues NEC,Lifestyle issues,SocCi,N
595,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
596,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
597,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
597,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
597,3,Neck injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
598,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
598,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
598,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
599,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
599,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
599,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
599,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
600,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
600,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
600,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
600,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
600,5,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
601,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
602,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
603,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
604,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
605,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
605,2,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
606,1,Tonsillar disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
607,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
607,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
607,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
607,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
607,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
608,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
609,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
610,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
611,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
611,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
612,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
612,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
613,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
614,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
615,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
616,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
616,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
616,3,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
617,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
618,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
619,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
619,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
619,3,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
619,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
619,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
620,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
620,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
620,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
620,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
620,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
620,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
620,7,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
620,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
620,9,Product contamination microbial,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
620,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
621,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
622,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
622,2,Pituitary-dependent Cushing's syndrome,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
623,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
624,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
625,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
626,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
626,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
626,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
627,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
628,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
629,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
629,2,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
629,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
630,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
630,2,Meningitis pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
630,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
630,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
630,5,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
631,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
632,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
633,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
634,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
634,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
634,3,Urinary tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
635,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
636,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
636,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
637,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
638,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
638,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
639,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
640,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
640,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
641,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
641,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
642,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
643,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
644,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
645,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
645,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
646,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
647,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
647,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
647,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
648,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
649,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
650,1,Insulin-like growth factor decreased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
651,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
652,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
652,2,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
652,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
652,4,Headache,Headaches NEC,Headaches,Nerv,N
652,5,Migraine,Migraine headaches,Headaches,Nerv,N
653,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
653,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
653,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
653,4,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
654,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
655,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
656,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
656,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
656,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
656,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
657,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
658,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
658,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
658,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
658,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
658,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
658,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
658,7,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
659,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
660,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
660,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
660,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
660,4,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
661,1,Ependymoma malignant,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
662,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
663,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
664,1,Injection site dermatitis,Injection site reactions,Administration site reactions,Genrl,N
665,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
666,1,Growth accelerated,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
666,2,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
667,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
668,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
668,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
669,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
670,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
670,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
671,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
672,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
673,1,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
673,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
674,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
674,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
675,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
676,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
676,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
676,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
677,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
677,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
677,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
677,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
677,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
677,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
678,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
679,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
679,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
680,1,Device dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
680,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
680,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
681,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
682,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
683,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
684,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
684,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
684,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
684,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
685,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
685,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
686,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
686,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
686,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
687,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
687,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
688,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
689,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
690,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
691,1,Headache,Headaches NEC,Headaches,Nerv,N
692,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
692,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
693,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
693,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
693,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
694,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
695,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
696,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
696,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
697,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
698,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
698,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
698,3,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
699,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
700,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
701,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
702,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
702,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
703,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
704,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
704,2,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
705,1,Expired device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
705,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
706,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
707,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
707,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
707,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
708,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
708,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
708,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
709,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
709,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
710,1,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
711,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
712,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
713,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
713,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
713,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
713,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
714,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
715,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
715,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
715,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
716,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
716,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
716,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
717,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
718,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
719,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
720,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
720,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
721,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
721,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
722,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
722,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
723,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
723,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
723,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
723,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
724,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
724,2,Aortic stenosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
724,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
724,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
724,5,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
724,6,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
724,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
724,8,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
724,9,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
724,10,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
724,11,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
724,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
724,13,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
724,14,Self-medication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
725,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
725,2,Growth hormone deficiency,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
726,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
726,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
727,1,Device leakage,Device issues NEC,Device issues,Prod,N
727,2,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
727,3,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
728,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
728,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
729,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
729,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
730,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
731,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
731,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
732,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
732,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
732,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
733,1,Orthopaedic procedure,Bone therapeutic procedures NEC,Bone and joint therapeutic procedures,Surg,N
734,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
735,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
735,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
735,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
735,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
736,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
736,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
737,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
737,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
738,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
738,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
738,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
738,4,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
739,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
740,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
740,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
740,3,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
740,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
741,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
741,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
741,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
741,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
742,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
743,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
743,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
743,3,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
744,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
745,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
746,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
747,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
748,1,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
749,1,Headache,Headaches NEC,Headaches,Nerv,N
750,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
750,2,Device physical property issue,Device physical property and chemical issues,Device issues,Prod,N
750,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
750,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
751,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
752,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
753,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
753,2,Deafness,Hearing losses,Hearing disorders,Ear,N
753,3,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
753,4,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
754,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
755,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
755,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
756,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
757,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
758,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
758,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
758,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
758,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
759,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
760,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
760,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
761,1,Device issue,Device issues NEC,Device issues,Prod,N
761,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
761,3,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
762,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
762,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
762,3,Device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
763,1,Device information output issue,Device information output issues,Device issues,Prod,N
763,2,Device issue,Device issues NEC,Device issues,Prod,N
763,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
763,4,Expired device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
763,5,Headache,Headaches NEC,Headaches,Nerv,N
764,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
764,2,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
764,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
764,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
765,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
765,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
765,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
765,4,Headache,Headaches NEC,Headaches,Nerv,N
765,5,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
765,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
765,7,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
765,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
765,9,Tension headache,Headaches NEC,Headaches,Nerv,N
766,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
766,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
767,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
767,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
767,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
768,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
768,2,Device issue,Device issues NEC,Device issues,Prod,N
768,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
768,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
768,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
769,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
770,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
770,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
771,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
771,2,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
771,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
771,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
772,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
772,2,Device issue,Device issues NEC,Device issues,Prod,N
772,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
772,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
772,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
772,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
772,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
773,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
773,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
773,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
774,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
774,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
774,3,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
774,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
775,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
775,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
775,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
776,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
777,1,Device issue,Device issues NEC,Device issues,Prod,N
777,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
778,1,Device power source issue,Device malfunction events NEC,Device issues,Prod,N
778,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
779,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
780,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
780,2,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
780,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
780,4,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
780,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
780,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
781,1,Device information output issue,Device information output issues,Device issues,Prod,N
781,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
782,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
782,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
783,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
783,2,Device issue,Device issues NEC,Device issues,Prod,N
783,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
783,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
783,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
784,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
784,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
785,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
786,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
787,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
787,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
788,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
789,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
789,2,Pituitary tumour recurrent,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
790,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
790,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
790,3,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
791,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
792,1,Blood sodium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
793,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
793,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
793,3,Device issue,Device issues NEC,Device issues,Prod,N
793,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
793,5,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
793,6,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
793,7,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
793,8,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
793,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
793,10,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
793,11,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
793,12,Thyroxine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
794,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
795,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
796,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
797,1,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
797,2,Headache,Headaches NEC,Headaches,Nerv,N
798,1,Device issue,Device issues NEC,Device issues,Prod,N
798,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
799,1,Polycystic ovaries,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
800,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
801,1,Headache,Headaches NEC,Headaches,Nerv,N
802,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
802,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
803,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
804,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
805,1,Limb asymmetry,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
806,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
806,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
807,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
807,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
808,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
809,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
809,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
809,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
809,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
810,1,Device issue,Device issues NEC,Device issues,Prod,N
810,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
811,1,Device leakage,Device issues NEC,Device issues,Prod,N
811,2,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
811,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
812,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
812,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
813,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
814,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
814,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
814,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
815,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
816,1,Device leakage,Device issues NEC,Device issues,Prod,N
816,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
816,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
817,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
817,2,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
818,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
819,1,Blood growth hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
820,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
820,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
821,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
822,1,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
823,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
823,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
823,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
823,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
823,5,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
823,6,Neck injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
823,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
824,1,Device dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
824,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
824,3,Multiple use of single-use product,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
825,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
825,2,Headache,Headaches NEC,Headaches,Nerv,N
826,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
826,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
827,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
828,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
828,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
828,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
829,1,Headache,Headaches NEC,Headaches,Nerv,N
830,1,Headache,Headaches NEC,Headaches,Nerv,N
831,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
831,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
832,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
832,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
833,1,Device issue,Device issues NEC,Device issues,Prod,N
833,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
833,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
833,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
834,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
835,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
836,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
837,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
837,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
837,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
838,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
838,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
838,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
839,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
840,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
840,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
841,1,Laziness,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
841,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
841,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
842,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
842,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
842,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
842,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
843,1,Blood growth hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
843,2,Headache,Headaches NEC,Headaches,Nerv,N
844,1,Headache,Headaches NEC,Headaches,Nerv,N
845,1,Device issue,Device issues NEC,Device issues,Prod,N
845,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
845,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
845,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
845,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
845,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
845,7,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
846,1,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
846,2,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
846,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
847,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
847,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
847,3,Intercepted product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
847,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
847,5,Recalled product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
848,1,Headache,Headaches NEC,Headaches,Nerv,N
848,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
849,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
850,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
850,2,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
850,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
851,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
851,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
852,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
853,1,Headache,Headaches NEC,Headaches,Nerv,N
853,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
853,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
853,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
853,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
853,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
854,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
854,2,Learning disability,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
855,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
856,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
856,2,Device leakage,Device issues NEC,Device issues,Prod,N
856,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
856,5,Hypermetropia,Refractive and accommodative disorders,Vision disorders,Eye,N
856,6,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
856,7,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
857,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
857,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
857,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
858,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
859,1,Blood growth hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
859,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
860,1,Blood growth hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
860,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
860,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
860,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
861,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
862,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
863,1,Headache,Headaches NEC,Headaches,Nerv,N
863,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
864,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
865,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
865,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
866,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
866,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
867,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
867,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
867,3,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
867,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
868,1,Device failure,Device issues NEC,Device issues,Prod,N
868,2,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
868,3,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
869,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
869,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
870,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
871,1,Brain operation,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
871,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
872,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
872,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
873,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
873,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
874,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
875,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
876,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
877,1,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
877,2,Lack of injection site rotation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
878,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
878,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
878,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
879,1,Deafness,Hearing losses,Hearing disorders,Ear,N
880,1,Hospice care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
881,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
881,2,Headache,Headaches NEC,Headaches,Nerv,N
881,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
883,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
884,1,Headache,Headaches NEC,Headaches,Nerv,N
884,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
885,1,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
885,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
886,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
886,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
887,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
888,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
889,1,Abscess oral,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
890,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
890,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
891,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
891,2,Headache,Headaches NEC,Headaches,Nerv,N
892,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
893,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
893,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
893,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
893,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
894,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
895,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
895,2,Headache,Headaches NEC,Headaches,Nerv,N
895,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
896,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
896,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
896,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
897,1,Headache,Headaches NEC,Headaches,Nerv,N
897,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
897,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
897,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
898,1,Device information output issue,Device information output issues,Device issues,Prod,N
898,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
899,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
900,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
900,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
901,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
901,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
902,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
902,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
903,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
904,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
905,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
905,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
906,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
906,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
907,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
907,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
907,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
908,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
908,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
908,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
909,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
909,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
910,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
910,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
910,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
911,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
911,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
912,1,Vein collapse,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
913,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
913,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
913,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
913,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
914,1,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
915,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
916,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
916,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
916,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
916,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
917,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
918,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
918,2,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
919,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
919,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
920,1,Liposarcoma,Liposarcomas malignant,Soft tissue neoplasms malignant and unspecified,Neopl,N
920,2,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
920,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
921,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
922,1,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
923,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
923,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
924,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
924,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
925,1,Arthropod sting,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
926,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
927,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
927,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
927,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
928,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
929,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
930,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
931,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
932,1,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
932,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
932,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
933,1,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
934,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
934,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
935,1,Device information output issue,Device information output issues,Device issues,Prod,N
935,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
935,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
935,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
936,1,Device issue,Device issues NEC,Device issues,Prod,N
936,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
937,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
938,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
939,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
940,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
941,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
941,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
941,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
941,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
941,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
941,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
941,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
941,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
942,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
942,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
942,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
942,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
943,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
943,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
943,3,Device issue,Device issues NEC,Device issues,Prod,N
943,4,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
943,5,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
943,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
943,7,Headache,Headaches NEC,Headaches,Nerv,N
943,8,Learning disability,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
943,9,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
944,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
944,2,Headache,Headaches NEC,Headaches,Nerv,N
944,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
944,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
945,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
945,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
946,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
946,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
946,3,Device leakage,Device issues NEC,Device issues,Prod,N
946,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
947,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
947,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
948,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
948,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
949,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
949,2,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
950,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
951,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
951,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
952,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
953,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
953,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
954,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
954,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
954,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
954,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
954,5,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
955,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
956,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
957,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
957,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
957,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
958,1,Intracranial mass,Structural brain disorders NEC,Structural brain disorders,Nerv,N
959,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
959,2,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
960,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
960,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
960,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
960,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
961,1,Drug administered in wrong device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
961,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
961,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
961,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
961,5,Packaging design issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
961,6,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
962,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
962,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
963,1,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
964,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
964,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
964,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
965,1,Benign neoplasm,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
965,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
966,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
966,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
966,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
967,1,Insulin-like growth factor decreased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
967,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
968,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
968,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
968,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
969,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
970,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
970,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
970,3,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
971,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
971,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
972,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
972,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
973,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
973,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
973,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
974,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
975,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
975,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
976,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
977,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
978,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
978,2,Migraine,Migraine headaches,Headaches,Nerv,N
979,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
979,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
980,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
980,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
980,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
981,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
981,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
982,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
982,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
983,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
983,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
984,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
985,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
985,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
985,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
985,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
986,1,Device issue,Device issues NEC,Device issues,Prod,N
986,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
987,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
988,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
989,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
989,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
990,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
991,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
992,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
993,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
993,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
993,3,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
994,1,Headache,Headaches NEC,Headaches,Nerv,N
995,1,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
996,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
996,2,Headache,Headaches NEC,Headaches,Nerv,N
996,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
996,4,Pyelocaliectasis,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
996,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
996,6,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
997,1,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
998,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
998,2,Pharyngeal operation,Pharyngeal therapeutic procedures,Head and neck therapeutic procedures,Surg,N
998,3,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
999,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
999,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1000,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1000,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1001,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1002,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1002,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1002,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1003,1,Device issue,Device issues NEC,Device issues,Prod,N
1003,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1003,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1004,1,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1005,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1005,2,Device end of service,Device issues NEC,Device issues,Prod,N
1005,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1005,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1006,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1007,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1008,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1008,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1009,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1009,2,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1009,3,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1009,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1010,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1010,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1011,1,Hand fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1012,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1013,1,Device issue,Device issues NEC,Device issues,Prod,N
1013,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1014,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1015,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1015,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1016,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1016,2,Device issue,Device issues NEC,Device issues,Prod,N
1016,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1016,4,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1016,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1016,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1016,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1016,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1017,1,Administration site haemorrhage,Administration site reactions NEC,Administration site reactions,Genrl,N
1017,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1017,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1018,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1019,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
1019,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1020,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1021,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1021,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1022,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1022,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1023,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1023,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1024,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1025,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1026,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1027,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1027,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1028,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1029,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1030,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1030,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1031,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1032,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1032,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1032,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1032,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1033,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1033,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1033,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1033,4,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1033,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1033,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1033,7,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1033,8,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1033,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
1034,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1035,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1035,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1036,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1036,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1037,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1038,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1038,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1038,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1038,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1039,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1040,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1040,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1040,3,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1040,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1040,5,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1040,6,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1040,7,Headache,Headaches NEC,Headaches,Nerv,N
1040,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1041,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1042,1,Morning sickness,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1043,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
1044,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1044,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1045,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1045,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1046,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1046,2,Headache,Headaches NEC,Headaches,Nerv,N
1046,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1047,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1047,2,Product dispensing issue,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1047,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1048,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1049,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1050,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1051,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1051,2,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1051,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1052,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1052,2,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1052,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1053,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1054,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1054,2,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1054,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1055,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1055,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1056,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1056,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1057,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1057,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1058,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1059,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1060,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
1060,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1060,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1061,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1061,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1062,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1062,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1063,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1063,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1063,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1064,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1064,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1064,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1065,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1066,1,Headache,Headaches NEC,Headaches,Nerv,N
1067,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1067,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1068,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1068,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1068,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1069,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1069,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1070,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1070,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1070,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1071,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1072,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1073,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1074,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1075,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1075,2,Headache,Headaches NEC,Headaches,Nerv,N
1075,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1076,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1076,2,Lack of injection site rotation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1076,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1076,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1077,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1077,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1078,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1079,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1080,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1080,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1080,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1081,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1082,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1082,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1082,3,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1083,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1084,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1085,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1085,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1086,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1086,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1087,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1087,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1087,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1088,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1089,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1089,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1089,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1090,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1091,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1091,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1092,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1093,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1093,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1094,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1094,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1095,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1095,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1096,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1097,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1098,1,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1099,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
1100,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1100,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1101,1,Device issue,Device issues NEC,Device issues,Prod,N
1101,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1102,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1103,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1104,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1105,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1105,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1106,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1107,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1108,1,Device leakage,Device issues NEC,Device issues,Prod,N
1108,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1108,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1108,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1109,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1109,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1109,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1109,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1109,5,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1109,6,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1109,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1109,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1109,9,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1110,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1111,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1111,2,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1111,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1111,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1112,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1112,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1113,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1114,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1114,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
1114,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1114,4,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
1115,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1115,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1116,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1116,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1116,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1117,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1118,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1119,1,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1119,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1120,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1120,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1121,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1121,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1122,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1122,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1122,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1123,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1123,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1123,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1124,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1124,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1124,3,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1124,4,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1124,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1124,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1124,7,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1125,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1125,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1126,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1127,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1127,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1127,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1128,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1128,2,Infantile vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1128,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1129,1,Device information output issue,Device information output issues,Device issues,Prod,N
1129,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1129,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1129,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1129,5,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1130,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1130,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1131,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1131,2,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
1132,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1133,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1133,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1133,3,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1133,4,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1133,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1133,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1133,7,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1134,1,Device power source issue,Device malfunction events NEC,Device issues,Prod,N
1134,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1135,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1136,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1136,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1136,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1137,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1137,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1138,1,Immobile,Disability issues,Lifestyle issues,SocCi,N
1139,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1140,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1141,1,Device issue,Device issues NEC,Device issues,Prod,N
1141,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1142,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1142,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1143,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1143,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1143,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1144,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1144,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1145,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1145,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1145,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1146,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1146,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1147,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1148,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1148,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1149,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1149,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1149,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1150,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1151,1,Device information output issue,Device information output issues,Device issues,Prod,N
1151,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1152,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1152,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1152,3,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1152,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1153,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1153,2,Headache,Headaches NEC,Headaches,Nerv,N
1154,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1155,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1155,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1155,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1156,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
1157,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1158,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1159,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1159,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1160,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1160,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1160,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1161,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1161,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1161,3,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1162,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1162,2,Lipoedema,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
1162,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
1163,1,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1163,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1164,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1164,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1165,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1165,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1166,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1167,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1168,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1169,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1170,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1170,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1171,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1172,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1172,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1172,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1172,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1173,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1173,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1174,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1175,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1176,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1176,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1176,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1176,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1177,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1178,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1179,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1179,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1180,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1180,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1180,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1180,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1181,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1181,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1181,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1181,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1182,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1182,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1182,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1183,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1183,2,Headache,Headaches NEC,Headaches,Nerv,N
1183,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1183,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1184,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1185,1,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1186,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1186,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1186,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1187,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1187,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1188,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1189,1,Headache,Headaches NEC,Headaches,Nerv,N
1189,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1189,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1189,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1189,5,Testicular cyst,Testicular and epididymal neoplasms,Testicular and epididymal disorders,Repro,N
1190,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1191,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1191,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1192,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1192,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1192,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1193,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1193,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1193,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1194,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1195,1,Headache,Headaches NEC,Headaches,Nerv,N
1195,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1195,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1196,1,Counterfeit product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1196,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1197,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1197,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1197,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1198,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1198,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1199,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1199,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1199,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1199,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1199,5,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1200,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1201,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1201,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1202,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1203,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1203,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1204,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1204,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1205,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1206,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1207,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1208,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1209,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1209,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1210,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1210,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1211,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1212,1,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1212,2,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1213,1,Device issue,Device issues NEC,Device issues,Prod,N
1213,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1214,1,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1214,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1215,1,Growth hormone deficiency,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
1216,1,Device failure,Device issues NEC,Device issues,Prod,N
1217,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1218,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1218,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
1219,1,Device issue,Device issues NEC,Device issues,Prod,N
1219,2,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1219,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1219,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1219,5,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1220,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1220,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1220,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1221,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1222,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1223,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1224,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1225,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1226,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1226,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1227,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1227,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
1227,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1228,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1228,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1228,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1228,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1229,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1230,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1231,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1232,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1233,1,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1233,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1234,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1235,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1235,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1235,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1236,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1237,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
1238,1,Headache,Headaches NEC,Headaches,Nerv,N
1239,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1240,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1240,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1241,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1241,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1242,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1243,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1244,1,Device material opacification,Device physical property and chemical issues,Device issues,Prod,N
1244,2,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1245,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1245,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1246,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1246,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1247,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1248,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1249,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1250,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1250,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1251,1,Headache,Headaches NEC,Headaches,Nerv,N
1252,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1253,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1253,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1253,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1254,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1255,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1255,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1256,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1257,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1258,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1258,2,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1258,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1258,4,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
1259,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1260,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1260,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1261,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1262,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1262,2,Headache,Headaches NEC,Headaches,Nerv,N
1262,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1263,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1263,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1263,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1264,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1265,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1265,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1266,1,Cardiac operation,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
1267,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1267,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1268,1,Device issue,Device issues NEC,Device issues,Prod,N
1268,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1268,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1269,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1270,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1270,2,Cardiac operation,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
1270,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1270,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1270,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1270,6,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1271,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1271,2,Device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1272,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1272,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1273,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1274,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1274,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1275,1,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1276,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1277,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1277,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1277,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1278,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1278,2,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1279,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1279,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1280,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1280,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1281,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1281,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1281,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1282,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1282,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1283,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1284,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1284,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1285,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1285,2,Device issue,Device issues NEC,Device issues,Prod,N
1286,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1286,2,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1287,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1288,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1289,1,Headache,Headaches NEC,Headaches,Nerv,N
1290,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1290,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1290,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1291,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1292,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1292,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1293,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1294,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1295,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1295,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1296,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1296,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1297,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1298,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1299,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1299,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1299,3,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1300,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1300,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1301,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1301,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1301,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1302,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1303,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1304,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1305,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1305,2,Device information output issue,Device information output issues,Device issues,Prod,N
1305,3,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1305,4,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1305,5,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1305,6,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1306,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1306,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1307,1,Chemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
1308,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1309,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1310,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1310,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1310,3,Lack of injection site rotation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1311,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1312,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1313,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1314,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1315,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1316,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1317,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1318,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1318,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1319,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1320,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1321,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1321,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1321,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1321,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1322,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1322,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1322,3,Multiple use of single-use product,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1323,1,Headache,Headaches NEC,Headaches,Nerv,N
1323,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1324,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1324,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1325,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1325,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1325,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1326,1,Lumbar puncture,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1326,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1326,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1327,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1327,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1328,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1328,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1328,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1329,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1329,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1330,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1330,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1331,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1331,2,Expired device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1331,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1332,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1332,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1332,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1333,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1333,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1334,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1334,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1335,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1335,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1336,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1337,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1338,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1339,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1340,1,Device leakage,Device issues NEC,Device issues,Prod,N
1340,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1340,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1340,4,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1340,5,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1341,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1341,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1341,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1342,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1343,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1343,2,Headache,Headaches NEC,Headaches,Nerv,N
1344,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1345,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1345,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1345,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1345,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1346,1,Dark circles under eyes,Ocular disorders NEC,Eye disorders NEC,Eye,N
1346,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1346,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1347,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
1347,2,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1348,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1349,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1350,1,Device leakage,Device issues NEC,Device issues,Prod,N
1350,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1350,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1351,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1351,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1352,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1353,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1353,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1353,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1353,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1354,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1354,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1355,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1355,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1355,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1355,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1355,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1356,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1356,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1356,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1356,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1357,1,Lower respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
1358,1,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
1359,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1359,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1359,3,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1360,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1361,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1362,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1363,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1364,1,Headache,Headaches NEC,Headaches,Nerv,N
1365,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1366,1,Device-device incompatibility,Device incompatibility issues,Device issues,Prod,N
1366,2,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1366,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1367,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1367,2,Device leakage,Device issues NEC,Device issues,Prod,N
1367,3,Headache,Headaches NEC,Headaches,Nerv,N
1368,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1368,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1369,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1370,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1370,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1371,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1372,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1372,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1372,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1372,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1373,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1374,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1375,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1376,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1376,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1377,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1377,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1377,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1378,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1378,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1379,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1380,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1381,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1382,1,Device information output issue,Device information output issues,Device issues,Prod,N
1382,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1383,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1383,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1383,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1384,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1384,2,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
1385,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1386,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1386,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1386,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1386,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1386,5,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1387,1,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1387,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1387,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1388,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1389,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1389,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1390,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1390,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1391,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1391,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1392,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1392,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1393,1,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1394,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1394,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1394,3,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1395,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1395,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1395,3,Shunt malfunction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1396,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1396,2,Headache,Headaches NEC,Headaches,Nerv,N
1396,3,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1396,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1396,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1397,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1398,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1398,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1399,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1400,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1400,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1401,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1402,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1402,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1402,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1403,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1403,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1404,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1404,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1405,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1406,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1406,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1406,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1407,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1407,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1407,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1408,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1408,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1408,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1409,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1409,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1410,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1410,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1411,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1411,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1411,3,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1412,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1412,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1413,1,Brain tumour operation,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1413,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1413,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1414,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1414,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1415,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1415,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1415,3,Headache,Headaches NEC,Headaches,Nerv,N
1415,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1415,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1416,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1416,2,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
1416,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1416,4,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1417,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1417,2,Headache,Headaches NEC,Headaches,Nerv,N
1417,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1417,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1418,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
1418,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1418,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1418,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1419,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1419,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1420,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1421,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1422,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1422,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1423,1,Device information output issue,Device information output issues,Device issues,Prod,N
1423,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1423,3,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1424,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1425,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1426,1,Headache,Headaches NEC,Headaches,Nerv,N
1426,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1426,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1427,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1427,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1428,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1428,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1429,1,Headache,Headaches NEC,Headaches,Nerv,N
1430,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1430,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1431,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1431,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1432,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1432,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1433,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1434,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1434,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1434,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1435,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1435,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1435,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1436,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
1437,1,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1437,2,Growth hormone deficiency,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
1438,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1438,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1438,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1438,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1439,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1439,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1439,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1440,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1440,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1441,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1441,2,Needle track marks,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
1442,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1443,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1444,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1445,1,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1446,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1446,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1447,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1448,1,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
1449,1,Headache,Headaches NEC,Headaches,Nerv,N
1449,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1450,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1450,2,Headache,Headaches NEC,Headaches,Nerv,N
1450,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1451,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1452,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1452,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1452,3,Migraine,Migraine headaches,Headaches,Nerv,N
1453,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1454,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1454,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1454,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1454,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1454,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1454,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1454,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1455,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1456,1,Budd-Chiari syndrome,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1457,1,Headache,Headaches NEC,Headaches,Nerv,N
1457,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1457,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1458,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1459,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1460,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1460,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1461,1,Central hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1462,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1462,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1463,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1464,1,Drug-device incompatibility,Device incompatibility issues,Device issues,Prod,N
1464,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1465,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1466,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1467,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1468,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1468,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1468,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1469,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1469,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1469,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1469,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1470,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1470,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1471,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1471,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1471,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1472,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1473,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1473,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1473,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1474,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1475,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1475,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1475,3,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1475,4,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1475,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1476,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1477,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1478,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1479,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1479,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1480,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1481,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1482,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1482,2,Device issue,Device issues NEC,Device issues,Prod,N
1482,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1482,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1482,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1483,1,Inadvertent injection air bubble,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1483,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1483,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1484,1,Growth disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1485,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1486,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1486,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1486,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1486,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1487,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1487,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1488,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1489,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1489,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1490,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1491,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1492,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1492,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1492,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1493,1,Daydreaming,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1493,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1494,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1495,1,Device leakage,Device issues NEC,Device issues,Prod,N
1495,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1496,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1497,1,Headache,Headaches NEC,Headaches,Nerv,N
1497,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1497,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1498,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1499,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1500,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1501,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1501,2,Device information output issue,Device information output issues,Device issues,Prod,N
1501,3,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1501,4,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1501,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1502,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1503,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1503,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1503,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1504,1,Device leakage,Device issues NEC,Device issues,Prod,N
1504,2,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1504,3,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1505,1,Device issue,Device issues NEC,Device issues,Prod,N
1505,2,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
1506,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1507,1,Pityriasis rosea,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1507,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1508,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1509,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1509,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1510,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1511,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1512,1,Migraine,Migraine headaches,Headaches,Nerv,N
1513,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1514,1,Blood glucagon abnormal,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
1515,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1515,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1516,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1517,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1517,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1518,1,Blood growth hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1519,1,Brain operation,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1519,2,Hypophysectomy,Pituitary and hypothalamic therapeutic procedures,Endocrine gland therapeutic procedures,Surg,N
1519,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1520,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1521,1,Headache,Headaches NEC,Headaches,Nerv,N
1522,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1522,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1523,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1524,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1525,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1525,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1525,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1526,1,Tonsillectomy,Tonsillar therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1527,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1528,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1528,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1528,3,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1528,4,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1529,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1530,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1530,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1530,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1530,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1530,5,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1530,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1530,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1531,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1532,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1533,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1534,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1534,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1535,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1535,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1535,3,Headache,Headaches NEC,Headaches,Nerv,N
1535,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1536,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1536,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1536,3,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1537,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1537,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1537,3,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1538,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
1538,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1538,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1538,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1538,5,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1539,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1539,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1540,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1540,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1541,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1542,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1543,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1543,2,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1544,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
1544,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1545,1,Device issue,Device issues NEC,Device issues,Prod,N
1545,2,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1545,3,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
1545,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1545,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1545,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1546,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1546,2,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1547,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1548,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1549,1,Headache,Headaches NEC,Headaches,Nerv,N
1549,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1550,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1550,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1550,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1550,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1550,5,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1551,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1551,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1551,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1552,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1553,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1554,1,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
1555,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1556,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1556,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1556,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1557,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1557,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1558,1,Insulin-like growth factor abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1559,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1560,1,Headache,Headaches NEC,Headaches,Nerv,N
1560,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1561,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1561,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1562,1,Growth disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1563,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1563,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1564,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1564,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1565,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1565,2,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
1565,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1565,4,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1565,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1565,6,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1566,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1567,1,Insulin-like growth factor decreased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1568,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1568,2,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1569,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1569,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1570,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1570,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1571,1,Insulin-like growth factor abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1572,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1572,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1572,3,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
1573,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1574,1,Device failure,Device issues NEC,Device issues,Prod,N
1574,2,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1574,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1574,4,Expired device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1575,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1575,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1575,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1575,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1576,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1576,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1576,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1577,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1577,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1578,1,Headache,Headaches NEC,Headaches,Nerv,N
1578,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1579,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1579,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1580,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1580,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1581,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1581,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1581,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1581,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1581,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1582,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1583,1,Insulin-like growth factor abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1584,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1584,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1584,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1584,4,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1585,1,Headache,Headaches NEC,Headaches,Nerv,N
1586,1,Migraine,Migraine headaches,Headaches,Nerv,N
1586,2,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1587,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1587,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1587,3,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1588,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1588,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1589,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1590,1,Repetitive strain injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1591,1,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1592,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1593,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1594,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1594,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1595,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1596,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1596,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1596,3,Intentional device misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1597,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1598,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1599,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1599,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1599,3,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1599,4,Device operational issue,Device operational issues NEC,Device issues,Prod,N
1600,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1600,2,Headache,Headaches NEC,Headaches,Nerv,N
1600,3,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1600,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1600,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1601,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1601,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1602,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1603,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1604,1,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
1604,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1605,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1605,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1606,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1607,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1608,1,Headache,Headaches NEC,Headaches,Nerv,N
1608,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1608,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1609,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1610,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1610,2,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1610,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1610,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1610,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1611,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1612,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1613,1,Headache,Headaches NEC,Headaches,Nerv,N
1614,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1615,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1615,2,Headache,Headaches NEC,Headaches,Nerv,N
1615,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1615,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1615,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1616,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1616,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1617,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1617,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1618,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1618,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1619,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1619,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1620,1,Device information output issue,Device information output issues,Device issues,Prod,N
1620,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1620,3,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1620,4,Toe amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1621,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1622,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1623,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1623,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1624,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1624,2,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1625,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1626,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1627,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1628,1,Angioplasty,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
1628,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1628,3,Device calibration failure,Device issues NEC,Device issues,Prod,N
1628,4,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1628,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1628,6,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1629,1,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1630,1,Epiphyses premature fusion,Epiphyseal disorders,Bone disorders (excl congenital and fractures),Musc,N
1631,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1631,2,Intercepted medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1632,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1632,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1633,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1633,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1634,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1634,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1635,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1636,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1637,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1638,1,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
1639,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1639,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1639,3,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1640,1,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1641,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1641,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1642,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1643,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1643,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1643,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1643,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1644,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1645,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1645,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1646,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1646,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1647,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1647,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1648,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1649,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1649,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1650,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1650,2,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1650,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1651,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1652,1,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1652,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1653,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1653,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1654,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1655,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1656,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1656,2,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
1657,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1658,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1658,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1659,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1660,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1660,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1660,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1660,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1661,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1662,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1663,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1663,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1663,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1664,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1664,2,Device leakage,Device issues NEC,Device issues,Prod,N
1664,3,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1664,4,Intentional device use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1664,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1664,6,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1665,1,Blood growth hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1665,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1665,3,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1666,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1667,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1668,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1669,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1669,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1669,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1670,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1670,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1671,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1671,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1672,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1672,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1673,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1673,2,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1673,3,Device dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1673,4,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1673,5,Headache,Headaches NEC,Headaches,Nerv,N
1673,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1673,7,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
1673,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1674,1,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1674,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1674,3,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1675,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1675,2,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
1675,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1675,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1676,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1677,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1677,2,Headache,Headaches NEC,Headaches,Nerv,N
1677,3,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1678,1,Device issue,Device issues NEC,Device issues,Prod,N
1678,2,Device leakage,Device issues NEC,Device issues,Prod,N
1678,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1678,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1678,5,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1679,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1680,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1681,1,Headache,Headaches NEC,Headaches,Nerv,N
1681,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1682,1,Device issue,Device issues NEC,Device issues,Prod,N
1682,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1683,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1683,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1683,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1683,4,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1684,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1685,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1686,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1687,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1687,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1688,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1688,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1688,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1688,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1688,5,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1688,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1688,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1689,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1689,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1689,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1689,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1690,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1690,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1690,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1691,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1692,1,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1693,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1694,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1694,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1695,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1696,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1696,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1697,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1697,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1698,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1698,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1699,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1699,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1699,3,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1699,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1700,1,Device leakage,Device issues NEC,Device issues,Prod,N
1700,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1700,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1700,4,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1701,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1702,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1702,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1703,1,Device leakage,Device issues NEC,Device issues,Prod,N
1703,2,Device physical property issue,Device physical property and chemical issues,Device issues,Prod,N
1703,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1704,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1704,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1705,1,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1705,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1705,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1706,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1706,2,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1707,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1707,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1707,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1707,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1708,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1708,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1708,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1709,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1709,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1710,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1710,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1711,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1711,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1712,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1712,2,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
1712,3,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
1712,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1713,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1713,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1713,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1714,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1715,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1716,1,Aortic disorder,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1716,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1716,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1716,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1716,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1716,6,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1716,7,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1716,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1717,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1718,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1719,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1720,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1720,2,Device leakage,Device issues NEC,Device issues,Prod,N
1720,3,Device physical property issue,Device physical property and chemical issues,Device issues,Prod,N
1720,4,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1720,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1720,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1720,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1721,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1721,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1722,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1723,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1723,2,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1724,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
1725,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1725,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1726,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1727,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1727,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1728,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1729,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1729,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1730,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1731,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1731,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1731,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1731,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1731,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1732,1,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1733,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1734,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1735,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1736,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1737,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1738,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1738,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1739,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1740,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1740,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1741,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1742,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1743,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1743,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1743,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1743,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1743,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1744,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1744,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1745,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1746,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1746,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1747,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1748,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1749,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1750,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1751,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1752,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1753,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1753,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1754,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1754,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1754,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1754,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1754,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1755,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1756,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1757,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
1757,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1758,1,Headache,Headaches NEC,Headaches,Nerv,N
1759,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1760,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1760,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1760,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1761,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1762,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
1763,1,Expired device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1763,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1763,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1763,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1764,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1764,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1765,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1766,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1767,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1768,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1769,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1769,2,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1770,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1770,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1771,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1771,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1771,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1771,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1772,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1773,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1774,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1775,1,Insulin-like growth factor increased,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1776,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1776,2,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1776,3,Device leakage,Device issues NEC,Device issues,Prod,N
1776,4,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
1776,5,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1776,6,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1777,1,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1778,1,Headache,Headaches NEC,Headaches,Nerv,N
1778,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1778,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1779,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1780,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1781,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1782,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
